期刊
CURRENT RHEUMATOLOGY REPORTS
卷 20, 期 1, 页码 -出版社
SPRINGER
DOI: 10.1007/s11926-018-0712-x
关键词
Cellularsenescence; Fibrosis; Woundhealing; Aging; Senotherapeutics; Senolytics; Senomorphics; Inflammation
类别
资金
- Glenn/AFAR post-doctoral fellowship program for translational research on aging
- National Institutes of Health [HL092961, AG052958]
- John E. and Virginia H. Kunkel Family
Purpose of the Review Senescent cells have the capacity to both effect and limit fibrosis. Senotherapeutics target senescent cells to improve aging conditions. Here, we review the contexts in which senescent cells mediate wound healing and fibrotic pathology and the potential utility of senotherapeutic drugs for treatment of fibrotic disease. Recent Findings Multi-action and temporal considerations influence deleterious versus beneficial actions of senescent cells. Acutely generated senescent cells can limit proliferation, and the senescence-associated secretory phenotype (SASP) contains factors that can facilitate tissue repair. Long-lived senescent cells that evade clearance or are generated outside of programmed remodeling can deplete the progenitor pool to exhaust regenerative capacity and through the SASP, stimulate continual activation, leading to disorganized tissue architecture, fibrotic damage, sterile inflammation, and induction of bystander senescence. Summary Senescent cells contribute to fibrotic pathogenesis in multiple tissues, including the liver, kidney, and lung. Senotherapeutics may be a viable strategy for treatment of a range of fibrotic conditions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据